PURPOSE: To examine a model of melanoma progression based on vascular factors and the role of NF-kappa B in the vascular progression of melanoma. PATIENTS AND METHODS: A data set of 526 patients from the University of California San Francisco Melanoma Center with 2 years of follow-up or first relapse was studied. The impact of the presence or absence of various prognostic factors on overall survival of melanoma patients was assessed using Cox regression and Kaplan-Meier analysis. A matched-pair analysis of NF-kappa B expression was performed in cases with vascular involvement and increased tumor vascularity versus matched controls lacking these factors. RESULTS: Cox regression analysis of factors evaluated by the American Joint Committee on Cancer Melanoma Staging Committee reproduced the powerful impact of tumor thickness and ulceration in this data set. With the inclusion of vascular factors such as tumor vascularity and vascular involvement, ulceration was no longer significant in predicting overall survival. By multivariate analysis, vascular involvement and tumor vascularity were the strongest predictors of melanoma outcome. Tumor vascularity seems to be a precursor of both vascular involvement and ulceration. A matched-pair tissue array analysis demonstrated the significant correlation between overexpression of NF-kappa B-p65 and the development of vascular factors. CONCLUSION: Vascular factors play an important role in the progression of malignant melanoma. Ulceration may be a surrogate marker for the interactions between melanoma and the tumor vasculature. NF-kappa B seems to play an important role in the development of these factors.
PURPOSE: To examine a model of melanoma progression based on vascular factors and the role of NF-kappa B in the vascular progression of melanoma. PATIENTS AND METHODS: A data set of 526 patients from the University of California San Francisco Melanoma Center with 2 years of follow-up or first relapse was studied. The impact of the presence or absence of various prognostic factors on overall survival of melanomapatients was assessed using Cox regression and Kaplan-Meier analysis. A matched-pair analysis of NF-kappa B expression was performed in cases with vascular involvement and increased tumor vascularity versus matched controls lacking these factors. RESULTS: Cox regression analysis of factors evaluated by the American Joint Committee on Cancer Melanoma Staging Committee reproduced the powerful impact of tumor thickness and ulceration in this data set. With the inclusion of vascular factors such as tumor vascularity and vascular involvement, ulceration was no longer significant in predicting overall survival. By multivariate analysis, vascular involvement and tumor vascularity were the strongest predictors of melanoma outcome. Tumor vascularity seems to be a precursor of both vascular involvement and ulceration. A matched-pair tissue array analysis demonstrated the significant correlation between overexpression of NF-kappa B-p65 and the development of vascular factors. CONCLUSION: Vascular factors play an important role in the progression of malignant melanoma. Ulceration may be a surrogate marker for the interactions between melanoma and the tumor vasculature. NF-kappa B seems to play an important role in the development of these factors.
Authors: Y Yang; C Gorzelanny; A T Bauer; N Halter; D Komljenovic; T Bäuerle; L Borsig; M Roblek; S W Schneider Journal: Oncogene Date: 2015-03-09 Impact factor: 9.867
Authors: Yuuki Iida; Aaron Ciechanover; Diego M Marzese; Keisuke Hata; Matias Bustos; Shigeshi Ono; Jinhua Wang; Matthew P Salomon; Kevin Tran; Stella Lam; Sandy Hsu; Nellie Nelson; Yelena Kravtsova-Ivantsiv; Gordon B Mills; Michael A Davies; Dave S B Hoon Journal: Clin Cancer Res Date: 2017-04-07 Impact factor: 12.531
Authors: David De Semir; Mehdi Nosrati; Vladimir Bezrookove; Altaf A Dar; Scot Federman; Geraldine Bienvenu; Suraj Venna; Javier Rangel; Joan Climent; Tanja M Meyer Tamgüney; Suresh Thummala; Schuyler Tong; Stanley P L Leong; Chris Haqq; Paul Billings; James R Miller; Richard W Sagebiel; Robert Debs; Mohammed Kashani-Sabet Journal: Proc Natl Acad Sci U S A Date: 2012-04-17 Impact factor: 11.205
Authors: Mohammed Kashani-Sabet; Suraj Venna; Mehdi Nosrati; Javier Rangel; Antje Sucker; Friederike Egberts; Frederick L Baehner; Jeff Simko; Stanley P L Leong; Chris Haqq; Axel Hauschild; Dirk Schadendorf; James R Miller; Richard W Sagebiel Journal: Clin Cancer Res Date: 2009-11-03 Impact factor: 12.531
Authors: Jessamy C Tiffen; Stuart J Gallagher; Hsin-Yi Tseng; Fabian V Filipp; Barbara Fazekas de St. Groth; Peter Hersey Journal: Pigment Cell Melanoma Res Date: 2016-05-25 Impact factor: 4.693
Authors: Mohammed Kashani-Sabet; Javier Rangel; Sima Torabian; Mehdi Nosrati; Jeff Simko; David M Jablons; Dan H Moore; Chris Haqq; James R Miller; Richard W Sagebiel Journal: Proc Natl Acad Sci U S A Date: 2009-03-30 Impact factor: 11.205